Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation…
News

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the…
Blog

BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the rapidly growing cytokines market

BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing
Qkine Limited and Akron Bio Announce Strategic Partnership image
News

Qkine Limited and Akron Bio Announce Strategic Partnership

Collaboration to Deliver High-Quality Cytokines and Growth Factors to Enable the Advancement of Stem Cell-Based Therapeutics
‍Qkine and Interlab announce distribution partnership in Taiwan image
Blog

‍Qkine and Interlab announce distribution partnership in Taiwan

‍Qkine and Interlab based in Taipei, Taiwan, partner to distribute Qkine high purity growth factors and cytokines, empowering research in Taiwan.
Qkine launches cell therapy grade recombinant proteins to support next-generation therapies image
Press Release

Qkine launches cell therapy grade recombinant proteins to support next-generation therapies

At Qkine we have repeatedly highlighted the need for stricter process and quality control in the manufacture of high purity in recombinant growth factors to prevent cross contamination with related growth factors. Contamination with other bioactive proteins leads to lack of inter and intra-lab reproducibility, or perhaps most concerningly incorrect scientific conclusions.
Last shipping dates of 2025 & first shipping dates of 2026 image
News

Updated shipping charges and options – September 2025

From 1st September, Qkine will be introducing updated delivery options designed to give you more choice, flexibility and reward ongoing support.
Qkine and 3D Bio-Tissues collaborate to improve cell-care for pluripotent stem cell and cellular agriculture…
News

Qkine and 3D Bio-Tissues collaborate to improve cell-care for pluripotent stem cell and cellular agriculture applications

This collaboration merges 3D Bio-Tissues novel macromolecular crowding technology with that of Qkine in complex protein manufacturing and engineering to allow testing and validation and improve culture performance and bioprocessing yields.
Introducing Quoll Biosciences – Qkine’s New Partner in Oceania image
News

Introducing Quoll Biosciences – Qkine’s New Partner in Oceania

Qkine announce distribution partnership with Quoll Biosciences, to supply Qkine high quality growth factors to Australia, New Zealand and Oceania.
Qkine and WildBio collaborate to progress cultivated meat from wild game species image
News

Qkine and WildBio collaborate to progress cultivated meat from wild game species

For the cultivated meat industry, the goal is to produce a quality raw material quickly and at a reduced cost. At WildBio, with help from Qkine, we are harnessing the power of cells from wild game species in South Africa.
Qkine and Tolemy Bio partner to advance media and protein optimization for cell therapy manufacturing image
News

Qkine and Tolemy Bio partner to advance media and protein optimization for cell therapy manufacturing

Qkine, a leading recombinant protein manufacturer, and Tolemy Bio, a pioneer in custom cell culture media design using AI, are excited to announce a collaborative partnership to drive innovation in cell and gene therapy (CGT) manufacturing.
Qkine announces partnership with REPROCELL image
News

Qkine announces partnership with REPROCELL

‍Qkine Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, and REPROCELL Inc., Japan’s first and leading induced pluripotent stem cell (iPSC) company, have partnered to globally distribute high-quality proteins such as growth factors and cytokines manufactured by Qkine.
Qkine join forces with Culturon to deliver cutting-edge solutions for the stem cell and life science industries image
News

Qkine join forces with Culturon to deliver cutting-edge solutions for the stem cell and life science industries

We are delighted to share that Culturon and Qkine have joined forces to deliver cutting-edge solutions for the stem cell and life science industries.
Shopping Basket